Clovis Oncology CLVS

Quarterly report 2022-Q3
added 11-09-2022

Clovis Oncology DIO Ratio 2011-2026 | CLVS

Annual DIO Ratio Clovis Oncology

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	271	279	448	855	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
855	271	463

Quarterly DIO Ratio Clovis Oncology

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	292	-	-	-	287	-	-	-	-	-	518	550	622	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
622	287	454

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Amarin Corporation plc AMRN	292	$ 14.81	-0.34 %	$ 6.04 B	Irlanda
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Aptorum Group Limited APM	4.89	$ 0.79	-7.27 %	$ 4.31 M	China
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Biogen BIIB	351	$ 195.63	0.06 %	$ 28.7 B	USA
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Bristol-Myers Squibb Company BMY	68.7	$ 60.51	1.12 %	$ 123 B	USA
	Arena Pharmaceuticals ARNA	160	-	-6.81 %	$ 3.04 B	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Amneal Pharmaceuticals AMRX	123	$ 14.8	1.13 %	$ 4.57 B	USA